Wijnand Helfrich

Prof. Wijnand Helfrich is a Professor at the University of Groningen’s Faculty of Medical Sciences, affiliated with the UMCG. He holds positions in the Onco-Immunology (O-I) and Translational Immunology Groningen (TRIGR) departments. He serves as Chair of the Dutch Tumor Immunology Meeting (DTIM). His research focuses on cancer immunotherapy, bispecific antibodies, and nanotechnology applications in oncology. Key areas include tumor antigen targeting, immune checkpoint inhibition, and engineered T cell therapies. Recent work explores fusion proteins, extracellular vesicles, and light-activated cytolytic agents. He supervises PhD student Douwe Samplonius and collaborates internationally. Public engagement includes fundraising for cancer research through events like the Tocht om de Noord.